28
Oct
2025

Sichuan Qingmu Pharma

Exhibitor at CPHI Frankfurt 2025 stand 11.0A83, API
About Us

Sichuan Qingmu Pharmaceuticals Co., Ltd. was established in 2011，which is mainly engaged in manufacturing of APIs and advanced intermediates. CMO/CDMO service is also included in the business scope. Qingmu have obtained GMP certificates for 10 APIs, 3 J-MFs, 1 USDMF, 2 USVMF and 1 CEP, and also passed the USFDA site inspection.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2023
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
View company profile
Contact info
  • 0086(028)87827187
  • Website
  • 55, South Shunjiang Avenue,, East Economic Development Zone, Dongpo District, 620036, Meishan, Sichuan, China
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 11.0A83, API

Products Featured at CPHI Frankfurt 2025

  • Apalutamide

    Product Apalutamide

    Grade:  Active Pharmaceutical Ingredient(API)Chemical name: 4-[7-[6-cyano-5-(trifluoromethyl)pyrid in-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide
    Molecular Formula: C21H15F4N5O2S
    Molecular Weight: 477.43g/mol
    Specifi...
  • Dabigatran Etexilate Mesylate

    Product Dabigatran Etexilate Mesylate

    Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Specifically it is used to prevent blood clots following hip or kn...
  • Sugammadex Sodium

    Product Sugammadex Sodium

    To facilitate tracheal intubation, mechanical ventilation, and surgical access, NMB agents are frequently used as non-anesthetic adjuncts in surgical procedures. Sugammadex is able to function as a pharmacologic sink of rocuronium and vecuronium, another non-depolarizing neuromuscular blocker, without the ...
  • Firocoxib

    Product Firocoxib

    Firocoxib is a selective inhibitor of COX-2 (IC50s = 0.13 and 7.5 μM for COX-2 and COX-1, respectively, in isolated cat blood). It inhibits LPS-induced production of prostaglandin E2 (PGE2; ) in isolated dog, horse, and cat whole blood ex vivo. Firocoxib decreases lameness, induces analgesia, and improves ...
  • Fluralaner

    Product Fluralaner

    Fluralaner(864731-61-3) is a novel systemically administered insecticidal and acaricidal compound that provides long-acting efficacy after oral administration to dogs. Fluralaner belongs to a new class of compounds, the isoxazolines. A field study has shown that a single fluralaner dose administered orally...